Ilaris – Canakinumab uses, dose and side effects
Ilaris contains the active substance kanakinumab, a monoclonal antibody, which belongs to a group of medicines called interleukin inhibitors. It blocks the effect of a substance in the body called interleukin 1-beta (IL 1-beta), which is found in increasing amounts in inflammatory diseases.
Read More